These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1363367)

  • 21. Molecular biology of lung cancer.
    Sozzi G
    Eur J Cancer; 2001 Oct; 37 Suppl 7():S63-73. PubMed ID: 11888007
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biology of small-cell bronchogenic carcinoma: recent advances].
    Levy R; Andrieu JM; Even P
    Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A translational view of the molecular pathogenesis of lung cancer.
    Sato M; Shames DS; Gazdar AF; Minna JD
    J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of genetic and molecular events in the pathogenesis of lung cancer.
    Johnson BE; Kelley MJ
    Chest; 1993 Jan; 103(1 Suppl):1S-3S. PubMed ID: 8380130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in understanding the molecular pathogenesis of human lung cancer.
    Sekido Y; Fong KM; Minna JD
    Biochim Biophys Acta; 1998 Aug; 1378(1):F21-59. PubMed ID: 9739759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
    Harris CC; Reddel R; Pfeifer A; Iman D; McMenamin M; Trump BF; Weston A
    IARC Sci Publ; 1991; (105):294-304. PubMed ID: 1855868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular biology of lung cancer.
    Gazdar AF
    Tohoku J Exp Med; 1992 Oct; 168(2):239-45. PubMed ID: 1306309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor genes in breast cancer: an overview.
    Steeg PS
    Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking and cancer.
    Carbone D
    Am J Med; 1992 Jul; 93(1A):13S-17S. PubMed ID: 1496998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour markers and oncogenes in lung cancer.
    Mäkelä TP; Mattson K; Alitalo K
    Eur J Cancer; 1991; 27(10):1323-7. PubMed ID: 1659844
    [No Abstract]   [Full Text] [Related]  

  • 31. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
    Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
    J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour suppressor genes and colorectal neoplasia.
    Koorey DJ; McCaughan GW
    J Gastroenterol Hepatol; 1993; 8(2):174-84. PubMed ID: 8471756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiators and promoters of lung cancer.
    Mulshine JL; Treston AM; Brown PH; Birrer MJ; Shaw GL
    Chest; 1993 Jan; 103(1 Suppl):4S-11S. PubMed ID: 8380133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
    Tripathy D; Benz CC
    Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic strategies of tumor suppression.
    Sager R
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S40-3. PubMed ID: 2174661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic characterization of neuroendocrine lung cancer cell lines.
    Lai SL; Brauch H; Knutsen T; Johnson BE; Nau MM; Mitsudomi T; Tsai CM; Whang-Peng J; Zbar B; Kaye FJ
    Anticancer Res; 1995; 15(2):225-32. PubMed ID: 7762988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer.
    Minna JD; Battey JF; Brooks BJ; Cuttitta F; Gazdar AF; Johnson BE; Ihde DC; Lebacq-Verheyden AM; Mulshine J; Nau MM
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():843-53. PubMed ID: 3472765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer.
    Viallet J; Minna JD
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):225-32. PubMed ID: 1968750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.